CytRx Corp. buy melinda
Start price
20.09.17
/
50%
€2.35
Target price
16.02.18
€3.61
Performance (%)
-39.85%
End price
16.02.18
€1.41
Summary
This prediction ended on 16.02.18 with a price of €1.41. The BUY prediction by melinda for CytRx Corp. performed very badly with a performance of -39.85%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$
(Vom Mitglied beendet)